HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yutaka Okita Selected Research

Sodium Hydroxide (Caustic Soda)

1/2012Topical application of basic fibroblast growth factor reduces esophageal stricture and esophageal neural damage after sodium hydroxide-induced esophagitis in rats.
1/2011Development of a model of benign esophageal stricture in rats: the optimal concentration of sodium hydroxide for stricture formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yutaka Okita Research Topics

Disease

21Aneurysm (Aneurysms)
11/2014 - 10/2003
14Infection
06/2015 - 12/2002
13Neoplasms (Cancer)
04/2013 - 09/2003
10Fistula
12/2014 - 12/2002
7Abdominal Aortic Aneurysm
09/2014 - 12/2003
6Hemorrhage
07/2015 - 11/2002
6Thoracic Aortic Aneurysm
10/2008 - 01/2003
5Ischemia
02/2015 - 04/2006
5Thrombosis (Thrombus)
01/2015 - 01/2002
5Aortic Aneurysm (Aneurysm, Aortic)
06/2014 - 07/2004
5Abscess
07/2013 - 09/2007
4Shock
11/2014 - 12/2003
4Necrosis
09/2014 - 06/2003
4Hypothermia
09/2014 - 02/2006
4False Aneurysm (Pseudoaneurysm)
07/2013 - 07/2004
3Pulmonary Embolism
01/2015 - 02/2006
3Endoleak
11/2014 - 09/2008
3Endocarditis
11/2014 - 06/2007
3Mitral Valve Insufficiency (Mitral Regurgitation)
01/2014 - 01/2006
3Heart Failure
08/2013 - 03/2002
3Body Weight (Weight, Body)
01/2012 - 06/2003
3Pathologic Constriction (Stenosis)
01/2011 - 11/2005
3Spinal Cord Ischemia
08/2010 - 01/2004
3Rupture
06/2005 - 12/2002
2Aortitis
09/2015 - 02/2009
2Aortic Valve Insufficiency (Aortic Regurgitation)
09/2015 - 07/2014
2Prolapse
09/2015 - 11/2011
2Inflammation
08/2015 - 11/2006
2Pulmonary Hypertension (Ayerza Syndrome)
01/2015 - 08/2014
2Stroke (Strokes)
11/2014 - 09/2014
2Mediastinitis
05/2014 - 09/2012
2Neurologic Manifestations (Neurological Manifestations)
03/2014 - 04/2013
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2013 - 03/2002
2Lung Neoplasms (Lung Cancer)
04/2013 - 11/2008
2Dissecting Aneurysm
09/2012 - 02/2009
2Esophageal Stenosis (Esophageal Stricture)
01/2012 - 01/2011
2Mesothelioma
02/2011 - 03/2007
2Hyperplasia
08/2010 - 05/2007
2Neoplasm Metastasis (Metastasis)
03/2009 - 06/2006
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2009 - 06/2007
2Ulcer
12/2006 - 08/2003
1Wound Infection (Wound Infections)
05/2014
1Atrial Heart Septal Defects (Atrial Septal Defect)
03/2014

Drug/Important Bio-Agent (IBA)

7Adenocarcinoma of lungIBA
04/2013 - 09/2003
4Messenger RNA (mRNA)IBA
09/2014 - 11/2005
4CollagenIBA
08/2013 - 07/2004
3tranilast (N 5')IBA
09/2015 - 07/2004
3nafamostatIBA
11/2014 - 06/2007
3rad9 proteinIBA
11/2008 - 01/2005
2allogenic effect factor (AEF)IBA
11/2014 - 10/2014
2GelatinIBA
09/2014 - 11/2011
2Coarctation of the aortaIBA
07/2014 - 04/2004
2Matrix MetalloproteinasesIBA
04/2014 - 06/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2014 - 06/2012
2CytokinesIBA
08/2013 - 06/2012
2nectinsIBA
04/2013 - 05/2010
2Immunoglobulins (Immunoglobulin)IBA
04/2013 - 05/2010
2Phenobarbital (Luminal)FDA Link
01/2012 - 03/2006
2Sodium Hydroxide (Caustic Soda)FDA Link
01/2012 - 01/2011
2Pancreatic Elastase (Elastase)IBA
10/2010 - 12/2009
2Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric
10/2010 - 12/2009
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
08/2010 - 05/2010
2FibrinIBA
05/2007 - 11/2005
2AntigensIBA
03/2007 - 09/2003
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2014
1Tissue Inhibitor of Metalloproteinases (TIMP)IBA
09/2014
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2014
1HydrogelIBA
09/2014
1Tissue Inhibitor of Metalloproteinase-2IBA
09/2014
18-hydroxy-2'-deoxyguanosineIBA
04/2014
1DNA (Deoxyribonucleic Acid)IBA
04/2014
1alogliptinIBA
04/2014
1dihydroethidiumIBA
04/2014
1Idiopathic pulmonary hypertensionIBA
03/2014

Therapy/Procedure

28Transplants (Transplant)
08/2015 - 12/2002
10Stents
11/2014 - 08/2003
8Cardiopulmonary Bypass (Heart-Lung Bypass)
02/2015 - 06/2003
7Homologous Transplantation (Allograft)
04/2013 - 12/2002
7Thoracotomy
01/2013 - 01/2003
4Sternotomy
06/2015 - 02/2006
4Tracheostomy
05/2014 - 10/2008
3Catheters
01/2015 - 12/2003
3Debridement
11/2014 - 01/2009
3Mitral Valve Annuloplasty
01/2014 - 01/2006
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2014 - 11/2005
3Drug Therapy (Chemotherapy)
01/2010 - 07/2004
2Artificial Respiration (Mechanical Ventilation)
07/2015 - 07/2010
2Angioplasty (Angioplasty, Transluminal)
01/2015 - 08/2014
2Endarterectomy (Thromboendarterectomy)
08/2014 - 02/2006
2Replantation
07/2014 - 12/2003
2Laparotomy
10/2012 - 12/2003
2Heterologous Transplantation (Xenotransplantation)
01/2009 - 03/2008
2Blood Vessel Prosthesis
05/2007 - 09/2006
2Balloon Occlusion
01/2004 - 12/2003
1Thrombolytic Therapy
01/2015
1Extracorporeal Membrane Oxygenation (ECMO)
01/2015
1Thrombectomy
01/2015
1Activities of Daily Living (ADL)
09/2014
1Induced Hypothermia
09/2014
1Renal Replacement Therapy (Therapies, Renal Replacement)
03/2014